NO20025968D0 - Pyridin-2-yl-aminoalkylkarbonylglycyl-<beta>-alanin og derivater derav - Google Patents

Pyridin-2-yl-aminoalkylkarbonylglycyl-<beta>-alanin og derivater derav

Info

Publication number
NO20025968D0
NO20025968D0 NO20025968A NO20025968A NO20025968D0 NO 20025968 D0 NO20025968 D0 NO 20025968D0 NO 20025968 A NO20025968 A NO 20025968A NO 20025968 A NO20025968 A NO 20025968A NO 20025968 D0 NO20025968 D0 NO 20025968D0
Authority
NO
Norway
Prior art keywords
aminoalkylcarbonylglycyl
pyridin
alanine
beta
derivatives
Prior art date
Application number
NO20025968A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025968L (no
Inventor
Guenter Hoelzemann
Simon Goodman
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20025968L publication Critical patent/NO20025968L/no
Publication of NO20025968D0 publication Critical patent/NO20025968D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20025968A 2000-06-13 2002-12-12 Pyridin-2-yl-aminoalkylkarbonylglycyl-<beta>-alanin og derivater derav NO20025968D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10028402A DE10028402A1 (de) 2000-06-13 2000-06-13 Pyridin-2-yl-aminoalkycarbonylglycyl-beta-alanin und Derivate
PCT/EP2001/006661 WO2001096365A1 (de) 2000-06-13 2001-06-12 PYRIDIN-2-YL-AMINOALKYLCARBONYLGLYCYL-β-ALANIN UND DERIVATE

Publications (2)

Publication Number Publication Date
NO20025968L NO20025968L (no) 2002-12-12
NO20025968D0 true NO20025968D0 (no) 2002-12-12

Family

ID=7645128

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025968A NO20025968D0 (no) 2000-06-13 2002-12-12 Pyridin-2-yl-aminoalkylkarbonylglycyl-<beta>-alanin og derivater derav

Country Status (18)

Country Link
US (1) US20030171304A1 (cs)
EP (1) EP1290010A1 (cs)
JP (1) JP2004503562A (cs)
KR (1) KR20030022145A (cs)
CN (1) CN1436196A (cs)
AR (1) AR028714A1 (cs)
AU (1) AU6606301A (cs)
BR (1) BR0111555A (cs)
CA (1) CA2414000A1 (cs)
CZ (1) CZ20023952A3 (cs)
DE (1) DE10028402A1 (cs)
HU (1) HUP0303716A2 (cs)
MX (1) MXPA02012411A (cs)
NO (1) NO20025968D0 (cs)
PL (1) PL358671A1 (cs)
SK (1) SK17112002A3 (cs)
WO (1) WO2001096365A1 (cs)
ZA (1) ZA200209410B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
EE200100651A (et) 1999-06-01 2003-02-17 Biogen, Inc. VLA-1 blokeeriv monoklonaalne antikeha ja tema kasutamine põletiku raviks
MXPA03009390A (es) 2001-04-13 2004-01-29 Biogen Inc Anticuerpos para integrina vla-1.
US7176322B2 (en) 2002-05-23 2007-02-13 Amgen Inc. Calcium receptor modulating agents
US6908935B2 (en) 2002-05-23 2005-06-21 Amgen Inc. Calcium receptor modulating agents
MXPA06010756A (es) 2004-03-24 2006-12-15 Jerini Ag Nuevos compuestos para la inhibicion de la angiogenesis y su uso.
US20090196912A1 (en) * 2004-07-30 2009-08-06 Gpc Botech Ag Pyridinylamines
PL2034830T3 (pl) 2006-05-25 2015-04-30 Biogen Ma Inc Przeciwciało anty-VLA-1 do leczenia udaru
WO2010057922A1 (en) * 2008-11-24 2010-05-27 Basf Se Curable composition comprising a thermolatent base
CN104271122A (zh) 2012-02-16 2015-01-07 桑塔鲁斯股份有限公司 抗vla1(cd49a)抗体药物组合物
MY208467A (en) * 2017-11-01 2025-05-11 Arrowhead Pharmaceuticals Inc Integrin ligands and uses thereof
CA3213968A1 (en) 2021-04-08 2022-10-13 Arrowhead Pharmaceuticals, Inc. Rnai agents for inhibiting expression of receptor for advanced glycation end-products, compositions thereof, and methods of use
WO2025152967A1 (zh) * 2024-01-15 2025-07-24 武汉人福创新药物研发中心有限公司 靶向αvβ6的化合物及其用途
WO2025152969A1 (zh) * 2024-01-15 2025-07-24 武汉人福创新药物研发中心有限公司 靶向化合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997024124A1 (en) * 1995-12-29 1997-07-10 Smithkline Beecham Corporation Vitronectin receptor antagonists

Also Published As

Publication number Publication date
EP1290010A1 (de) 2003-03-12
NO20025968L (no) 2002-12-12
ZA200209410B (en) 2004-02-19
CZ20023952A3 (cs) 2003-03-12
DE10028402A1 (de) 2001-12-20
US20030171304A1 (en) 2003-09-11
BR0111555A (pt) 2003-07-08
PL358671A1 (en) 2004-08-09
AU6606301A (en) 2001-12-24
CA2414000A1 (en) 2002-12-03
HUP0303716A2 (hu) 2004-03-01
KR20030022145A (ko) 2003-03-15
CN1436196A (zh) 2003-08-13
WO2001096365A1 (de) 2001-12-20
SK17112002A3 (sk) 2003-04-01
MXPA02012411A (es) 2003-04-25
AR028714A1 (es) 2003-05-21
JP2004503562A (ja) 2004-02-05

Similar Documents

Publication Publication Date Title
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
NO20024355D0 (no) Nukleosidforbindelser og anvendelser derav
NO991151D0 (no) Forbindelse og anvendelse derav
NO20024874L (no) Benzoamidpiperidin-inneholdende forbindelser og beslektede forbindelser
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20021379D0 (no) Benzodiazepin-derivater, fremstilling og anvendelse derav
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
DK1280809T3 (da) Antitumorecteinascidinderivater
ATE298332T1 (de) Decahydro-isochinolinderivate
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
DK1322597T3 (da) Fremgangsmåde og intermediære
NO20003916D0 (no) Benzotiadiazoler og derivater
NO20025968L (no) Pyridin-2-yl-aminoalkylkarbonylglycyl-&lt;beta&gt;-alanin og derivater derav
DK1106607T3 (da) Uracilforbindelser og anvendelse deraf
NO20014010L (no) &lt;beta&gt;-alaninderivater
DE69909843D1 (de) Automatische register- und längeeinstellung
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse
DK1246791T3 (da) Aminomethyl-phenyl-cyklohexanonderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application